CellWell record HH-2867
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
USPSTF, Screening for Prostate Cancer, Recommendation Statement
2018 (reaffirmed since) ยท 2018
In plain language
Men 55-69: individualized shared decision-making; men 70+: against routine screening; overdiagnosis estimated 16.4-50.4% across major trials.
- Design
- Clinical trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-2867
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.